SAB BIOTHERAPEUTICS INC
SABS · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $2.87
- Today’s Low
- $2.61
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $2.99
- Previous Close
- $2.83
- Volume
- 359.06K
- Market Cap
- $257.49M
- P/E Ratio
- 20.42X
- EPS
- $-1.41
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 777 W 41ST ST., MIAMI BEACH, FL, UNITED STATES, 33140
- Country
- US
- Listing Date
- 2021-01-12
- Fiscal Year End
- December
- Shares Outstanding
- 76.46M
- CIK
- 0001833214
- Website
- www.sab.bio
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. The company is headquartered in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$23.37M
2026-03-31
$19.24M
2025-12-31
$15M
2025-09-30
$11.91M
Net Income
2026-06-30
-$22.49M
2026-03-31
-$18.86M
2025-12-31
-$16.86M
2025-09-30
$45.44M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.28
2026-03-31
$-0.35
2025-12-31
$-0.41
2025-09-30
$0.50
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.59M
2026-03-31
-$18.05M
2025-12-31
-$16.03M
2025-09-30
$46.25M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $23.37M | $19.24M | $15M | $11.91M |
| Net Income | -$22.49M | -$18.86M | -$16.86M | $45.44M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.28 | $-0.35 | $-0.41 | $0.50 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.59M | -$18.05M | -$16.03M | $46.25M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.